SciTransfer
Organization

ISS BIOSENSE SRL

Italian SME developing portable photonic biosensors for rapid agri-food quality testing and veterinary disease diagnostics.

Technology SMEfoodITSME
H2020 projects
3
As coordinator
1
Total EC funding
€541K
Unique partners
23
What they do

Their core work

ISS BioSense is a Naples-based SME that develops portable biosensor devices for rapid on-site detection in agri-food and veterinary diagnostics. Their core work involves integrating photonic integrated circuits (PICs), plasmonics, and fluorescence-based sensing into compact analytical instruments. They have built expertise in automating lab-grade analysis — such as milk quality testing and swine disease screening — into field-deployable, low-cost sensor platforms suited for food supply chains and livestock health monitoring.

Core expertise

What they specialise in

Photonic biosensor developmentprimary
3 projects

All three H2020 projects (SWINOSTICS, I-Cuvette, GRACED) center on biosensing technologies using photonics, plasmonics, or fluorescence.

Veterinary point-of-care diagnosticssecondary
1 project

SWINOSTICS focused on field diagnostics for six major swine diseases (ASF, PRRS, CSF, PCV2, PPV, SIV) using PIC-based biosensors.

Agri-food quality and safety testingsecondary
2 projects

I-Cuvette targeted rapid milk analysis; GRACED addresses fruits and vegetables value chain monitoring.

Plasmo-photonic multiplexing sensorsemerging
1 project

GRACED (2021-2024) develops ultra-compact plasmo-photonic bimodal platforms with quantum dots and on-chip light generation — a clear technology step-up from earlier work.

Evolution & trajectory

How they've shifted over time

Early focus
Swine disease field diagnostics
Recent focus
Plasmo-photonic multiplexed food sensors

ISS BioSense started with established photonic integrated circuit (PIC) technology applied to veterinary diagnostics (SWINOSTICS, 2017) and simple portable fluorescence sensing for milk testing (I-Cuvette, 2017-2018). By 2021, their focus shifted toward more advanced plasmo-photonic platforms incorporating quantum dots, on-chip light generation, and multiplexed detection for agri-food value chains (GRACED). The trajectory shows a company moving from single-analyte portable testing toward multi-analyte, highly integrated sensor platforms with broader application scope.

ISS BioSense is moving toward miniaturized, multi-target sensor platforms that combine plasmonics and photonics — expect them to pursue applications beyond veterinary diagnostics into broader food safety and environmental monitoring.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European9 countries collaborated

ISS BioSense primarily participates as a specialist partner in larger consortia (2 of 3 projects), contributing biosensor device expertise to multi-partner research efforts. They coordinated one SME Phase 1 project (I-Cuvette), which suggests entrepreneurial ambition but limited experience leading large consortia. With 23 unique partners across 9 countries from just 3 projects, they integrate well into diverse European teams and bring a focused technical contribution rather than broad project management.

Despite only three projects, ISS BioSense has built a network of 23 partners across 9 countries, indicating they join sizeable, geographically diverse consortia. Their Italian base and agri-food focus likely connect them to Southern and Central European research groups in photonics and agricultural technology.

Why partner with them

What sets them apart

ISS BioSense sits at the intersection of advanced photonics and practical agri-food diagnostics — a niche that few SMEs occupy. While many biosensor companies stay in the lab or focus on human health, this team has consistently targeted agricultural and veterinary applications with field-deployable devices. For consortium builders, they offer a rare combination: deep photonic sensor engineering with direct understanding of food chain and livestock end-user requirements.

Notable projects

Highlights from their portfolio

  • GRACED
    Largest funding (EUR 258,438) and most technically ambitious project, combining plasmonics, quantum dots, and on-chip light generation into multiplexed sensor platforms for food value chains.
  • SWINOSTICS
    Addressed six major swine diseases in a single diagnostic toolbox — a high-impact veterinary application that demonstrates the company's ability to deliver multi-target biosensing in real field conditions.
  • I-Cuvette
    SME Phase 1 project where ISS BioSense was sole coordinator, validating their portable FRET-based milk analysis concept — signals independent product development ambition.
Cross-sector capabilities
Veterinary health and animal disease diagnosticsPhotonics and optical sensor hardwareEnvironmental monitoring and detectionDigital instrumentation and analytical automation
Analysis note: Profile based on only 3 H2020 projects (2017-2024). The technical direction is clear and consistent, but the small project count limits certainty about organizational capacity and full expertise breadth. No website available for verification of current commercial activities.